Figure 1From: Importance of competing risks in the analysis of anti-epileptic drug failure Distribution of withdrawal times for various reasons in the SANAD trial. Censored denoted by full shading, Unacceptable Adverse Event by /, Inadequate Seizure Control by X.Back to article page